Acquired long QT syndromes and the risk of proarrhythmia

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 8, 2000, Pages 938-940

  Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZIMILIDE; BEPRIDIL; CISAPRIDE; CLARITHROMYCIN; DISOPYRAMIDE; DOFETILIDE; ERYTHROMYCIN; HALOPERIDOL; NEUROLEPTIC AGENT; PENTAMIDINE; PROCAINAMIDE; QUINIDINE; SOTALOL; SPARFLOXACIN; SULFANILAMIDE; TEDISAMIL; TERFENADINE; TERODILINE; THIORIDAZINE; TRIMETHOPRIM;

CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; DRUG RESPONSE; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; TORSADE DES POINTES;

EID: 0033844532     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb00077.x     Document Type: Short Survey

References (7)

1. Taking the idio out of idiosyncratic: Predicting torsades de pointes
2. Increased sensitivity to QT prolonging drug therapy immediately after cardioversion to sinus rhythm
3. Proarrhythmic effects of the class III agent almokalant: Importance of infusion rate, QT dispersion, and early afterdepolarisations
4. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
5. ++ overload
6. Calmodulin kinase inhibition prevents development of the arrhythmogenic transient inward current
7. KCNE1 polymorphism confers risk of drug-induced long QT syndrome by altering kinetic properties of IKs potassium channels